$34.60
▼ -0.8% Today
as of Sep 4, 16:56 ET
Last 30 days
Recent Press Releases & News
Is Viking Therapeutics (VKTX) Stock Fully Priced After A 411% Run?
Viking Therapeutics, Inc. (VKTX) Outperforms Broader Market: What You Need to Know
3 Wall Street Analysts Think Viking Therapeutics Stock Will Roughly Triple Over the Next 12 Months. Here's Why I Think They're Wrong
Overview
52-week range
$23
$43
58% of range
Avg surprise (last 2)
-26.2%
Avg reaction (last 2)
+2.6%
100% positive
Latest IV / EM
71%
EM ±3.0% · $34 · Sep 4
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-1.10 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $-1.37 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.81 | — | — | — | — | financials |
| Wed Jul 23, 2025 | Jun/2025 | $-0.58 | $-0.44 | -31.8% | — | +4.0% | earnings |
| Wed Apr 23, 2025 | Mar/2025 | $-0.41 | $-0.34 | -20.6% | — | +1.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.22 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.20 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.26 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.23 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.19 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.25 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | $0 | $0 | $0 | — | $0 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-133M | $-164M | — | $-99M | $-75M | $-55M | — | $-37M |
| Net income | $-128M | $-158M | — | $-91M | $-66M | $-46M | — | $-25M |
| EPS (diluted) | $-1.10 | $-1.37 | — | $-0.81 | $-0.58 | $-0.41 | — | $-0.22 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $126M | $118M | $166M | $100M | $34M | $38M | $27M | $50M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $518M | $608M | $716M | $739M | $827M | $866M | $907M | $937M |
| Total assets | $522M | $608M | $716M | $739M | $828M | $867M | $908M | $938M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $114M | $106M | $77M | $26M | $32M | $20M | $28M | $26M |
| Total equity | $408M | $502M | $639M | $713M | $795M | $847M | $880M | $911M |